Shengfang Jin, ENSEM president and CSO

With an eye to 'non-ob­vi­ous bind­ing sites,' CBC Group launch­es pre­ci­sion med­i­cine play with $67M and ex-Ed­i­tas ex­ec at the helm

Over the past year, CBC Group has been qui­et­ly in­cu­bat­ing a biotech to take ad­van­tage of the AI rush and make some new ther­a­pies against …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.